Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Augusta Pharmaceuticals Inc
Profile last edited on: 1/3/17      CAGE: 5QKM4      UEI: GNV6VN6F4JA5

Business Identifier: Gene-therapy for cancer
Year Founded
2009
First Award
2010
Latest Award
2010
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

58 Oak Cliff Road
Newton, MA 02460
   (617) 965-9079
   dgrueneberg@augustapharma.com
   www.augustapharma.com
Location: Single
Congr. District: 04
County: Middlesex

Public Profile

Augusta Pharmaceuticals works in researching genetic technologies for application in cancer therapeutics. The company has used cutting edge genetic technologies and shRNA screening methodologies to uncover the ROS receptor tyrosine kinase as a cancer survival gene.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$203,208
Phase II Dollars
$0
Total Awarded
$203,208

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 1 NIH $203,208
Project Title: Tas::75 0849::Tas Development of Ros Kinase Inhibitors - Phase I SBIR Topic 255

Key People / Management

  Dorre A Grueneberg -- President

Company News

There are no news available.